THRD(Delisted)
Third Harmonic Bio·NASDAQ
--
--(--)
THRD fundamentals
During Q1 2025, Third Harmonic Bio (THRD) reported revenue of --, a YoY change of 0.00%. Net income was -15.83M, a YoY change of -101.55%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | TTM |
|---|
Start Date | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | -- |
End Date | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 5.70M -- | 5.75M -- | 7.79M -- | 7.78M -- | 8.59M +50.75% | 13.55M +135.61% | 11.99M +53.95% | 10.71M +37.66% | 10.85M +26.30% | 10.40M -23.21% | 11.29M -5.82% | 14.07M +31.32% | 17.07M +57.40% | -- -- | -- -- | -- -- |
Selling, General and Administrative Expenses | 780.00K -- | 1.47M -- | 1.57M -- | 3.60M -- | 3.83M +391.15% | 4.29M +192.84% | 5.25M +233.40% | 5.37M +49.19% | 4.88M +27.33% | 4.49M +4.52% | 5.06M -3.56% | 5.68M +5.62% | 5.73M +17.47% | -- -- | -- -- | -- -- |
Research and Development Expenses | 4.92M -- | 4.29M -- | 6.21M -- | 4.18M -- | 4.76M -3.25% | 9.26M +116.03% | 6.74M +8.45% | 5.34M +27.72% | 5.97M +25.48% | 5.92M -36.07% | 6.23M -7.58% | 8.39M +57.19% | 11.34M +90.03% | -- -- | -- -- | -- -- |
Operating Income | -5.70M -- | -5.75M -- | -7.79M -- | -7.78M -- | -8.59M -50.75% | -13.55M -135.61% | -11.99M -53.95% | -10.71M -37.66% | -10.85M -26.30% | -10.40M +23.21% | -11.29M +5.82% | -14.07M -31.32% | -17.07M -57.40% | -- -- | -- -- | -- -- |
Non-Operating Income (Loss) | -1.68M -- | -10.03M -- | 3.00K -- | 107.00K -- | 383.00K +122.74% | 2.06M +120.54% | 2.90M +96666.67% | 3.15M +2847.66% | 3.50M +814.88% | 3.57M +73.25% | 3.43M +18.29% | 3.36M +6.63% | 3.27M -6.56% | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -1.68M -- | -10.03M -- | 3.00K -- | 0 -- | 0 +100.00% | -2.00K +99.98% | -2.00K -166.67% | -4.00K -- | 34.00K -- | -6.00K -200.00% | 1.00K +150.00% | -1.00K +75.00% | -4.00K -111.76% | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -107.00K -- | -383.00K -- | -2.06M -- | -2.90M -- | -3.16M -2851.40% | -3.47M -806.01% | -3.58M -73.38% | -3.43M -18.18% | -3.36M -6.52% | -3.28M +5.53% | -- -- | -- -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | 107.00K -- | 383.00K -- | 2.06M -- | 2.90M -- | 3.16M +2851.40% | 3.47M +806.01% | 3.58M +73.38% | 3.43M +18.18% | 3.36M +6.52% | 3.28M -5.53% | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -7.38M -- | -15.78M -- | -7.78M -- | -7.68M -- | -8.21M -11.16% | -11.49M +27.20% | -9.09M -16.71% | -7.56M +1.51% | -7.34M +10.51% | -6.84M +40.50% | -7.86M +13.53% | -10.71M -41.63% | -13.80M -87.92% | -13.11M -91.73% | -15.83M -101.55% | -53.45M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -7.38M -- | -15.78M -- | -7.78M -- | -7.68M -- | -8.21M -11.16% | -11.49M +27.20% | -9.09M -16.71% | -7.56M +1.51% | -7.34M +10.51% | -6.84M +40.50% | -7.86M +13.53% | -10.71M -41.63% | -13.80M -87.92% | -13.11M -91.73% | -15.83M -101.55% | -53.45M -- |
Net Income Attributable to Owners of the Company | -7.38M -- | -15.78M -- | -7.78M -- | -7.68M -- | -8.21M -11.16% | -11.49M +27.20% | -9.09M -16.71% | -7.56M +1.51% | -7.34M +10.51% | -6.84M +40.50% | -7.86M +13.53% | -10.71M -41.63% | -13.80M -87.92% | -- -- | -- -- | -- -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -7.38M -- | -15.78M -- | -7.78M -- | -7.68M -- | -8.21M -11.16% | -11.49M +27.20% | -9.09M -16.71% | -7.56M +1.51% | -7.34M +10.51% | -6.84M +40.50% | -7.86M +13.53% | -10.71M -41.63% | -13.80M -87.92% | -- -- | -- -- | -- -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Basic EPS | -0.9 -- | -- -- | -0.81 -- | -1.76 -- | -0.9 -- | -0.29 -- | -0.23 +71.60% | -0.19 +89.20% | -0.19 +78.89% | -0.17 +41.38% | -0.2 +13.04% | -0.26 -36.84% | -0.33 -73.68% | -0.29 -70.59% | -0.35 -75.00% | -1.23 -- |
Diluted EPS | -0.9 -- | -- -- | -0.81 -- | -1.76 -- | -0.9 -- | -- -- | -0.23 +71.60% | -0.19 +89.20% | -0.19 +78.89% | -- -- | -0.2 +13.04% | -0.26 -36.84% | -0.33 -73.68% | -- -- | -0.35 -75.00% | -- -- |
You can ask Aime
No Data
